Background
Antiretroviral therapy (ART) blocks HIV-1 replication, yet some people with HIV (PWH) develop non-suppressible viremia (NSV). Clonally expanded infected CD4+ T cells, harboring defects in the 5’Leader region (5’L), contribute to persistent viremia in PWH with NSV. Production of viral proteins from these defective proviruses may drive immune dysfunction during ART. We recently observed that soluble gp120 (sgp120) and a family of gp120-specific anti-cluster A antibodies (Abs) were associated with inflammation and CD4+ T cells depletion in ART-treated PWH. However, whether 5’L defective proviruses can produce sgp120 and whether anti-cluster A Abs are negatively associated with CD4+ T cell counts in PWH with NSV remains unknown.
Methods
5’L deletions (3-41 nucleotides) or point mutations (T745A, T745C) found in PWH with NSV were introduced in a pNL4.3 and a CH58 transmitted-founder (TF) backbone (n=7 constructs per backbone). Envelope glycoprotein (Env) expression and production of sgp120 was assessed in transfected HEK293T cells. Supernatant of these transfected cells were tested for their ability to induce primary CD4+ T cell death via Antibody-Dependent Cellular Cytotoxicity (ADCC) using flow-cytometry based assays. Finally, we measured the levels of sgp120 and anti-cluster A Abs in the plasma of 12 ART-treated PWH with NSV to assess their association with CD4 counts.
Results
5’L defects significantly reduced Env expression at the cell-surface for both pNL4.3 (mean decrease of 59% sd±17%) and CH58TF (mean decrease of 61% sd±21%). Soluble gp120 was detected in the cell supernatant and correlated with cell-surface Env (Spearman r=0.86, p<0.0001). Supernatant of some constructs lead to ADCC-mediated killing of primary CD4+ T cells, which was associated with sgp120 levels (Spearman r=0.72, p=0.037). Plasmatic sgp120 was detected in 1/12 PWH, whose NSV was driven by a dominant clone harboring the T745A mutation. CD4 counts were negatively associated with anti-cluster A Abs (Spearman r= -0.72, p=0.009) but not with residual viremia (Spearman r= -0.26, p=0.43).
Conclusions
Our results show that 5’L defective proviruses produce sgp120, with some defects leading to CD4+ T cells depletion in vitro. Understanding the persistence of these clones in PWH and how they contribute to immune dysfunction is important to develop new strategies to improve the immune status of PWH with NSV.